Alex Therapeutics

The company develops evidence-based Software as a Medical Device (SaMD) products and digital companion apps designed to help patients manage medications and mental health challenges. They partner with pharmaceutical companies to provide AI-integrated tools specifically for patients with cancer, rare diseases, and chronic conditions like Parkinson’s and pulmonary fibrosis. These platforms focus on symptom tracking, treatment adherence, and behavioral change to improve clinical outcomes.